Interleukin ۱۷A: A Potential Target for Its Plausible Roles in the Pathogenesis of Idiopathic Epistaxis

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 148

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJOTO-34-1_006

تاریخ نمایه سازی: 11 دی 1400

چکیده مقاله:

Introduction:It has been reported that inflammation may be a potential risk factor for the progression of epistaxis. Due to the major roles played by Th۱۷ in the induction of inflammation, the present study aimed to assess the serum levels of Interleukin ۱۷A (IL-۱۷A) and IL-۲۳, as the most important cytokines in the Th۱۷ pathway, as well as IFN-g, IL-۴, and IL-۱۰ serum levels, as regulatory cytokines for Th۱۷ cells in patients with idiopathic epistaxis.  Materials and Methods:The serum levels of IL-۴, IL-۱۰, IL-۱۷A, IL-۲۳, and IFN-g were evaluated in ۹۰ patients with idiopathic epistaxis and ۹۰ healthy controls using enzyme-linked immunosorbent assay (ELISA) technique. Results:The obtained results pointed out that the serum levels of IL-۱۷A and IL-۱۰, but not IL-۴ and IL-۲۳, were significantly up-regulated, and IFN-g serum levels were significantly down-regulated in patients with idiopathic epistaxis. Furthermore, female patients with epistaxis had higher IL-۱۰ serum levels. Conclusions:As evidenced by the results of the present study, IL-۱۷A is the main cytokine which participates in the pathogenesis of idiopathic epistaxis; moreover, in association with IL-۱۰, it can be regarded as the suppressor of IFN-g in patients. 

کلیدواژه ها:

نویسندگان

Reza Nosratabadi

Department of Medical Immunology, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran

Ali Golshiri-Isfahani

Department of Otolaryngology, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

Soheila Rahmanzadeh-Shahi

Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

Gholamreza Asadikaram

Neuroscience Research Center, Institute of Neuropharmacology, and Department of Biochemistry, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran

Mohammad Kazemi Arababadi

Department. of Laboratory Sciences, Faculty of Paramedicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran